Neimeth International Pharmaceuticals Plc (NGX: NEIMETH)
Nigeria
· Delayed Price · Currency is NGN
2.040
+0.110 (5.70%)
At close: Sep 13, 2024
NEIMETH Revenue
Neimeth International Pharmaceuticals had revenue of 1.01B NGN in the quarter ending June 30, 2024, with 106.38% growth. This brings the company's revenue in the last twelve months to 2.91B, up 29.74% year-over-year. In the year 2023, Neimeth International Pharmaceuticals had annual revenue of 2.21B, down -24.31%.
Revenue (ttm)
2.91B
Revenue Growth
+29.74%
P/S Ratio
3.00
Revenue / Employee
14.40M
Employees
202
Market Cap
8.72B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.21B | -709.73M | -24.31% |
Dec 31, 2022 | 2.92B | 216.47M | 8.01% |
Sep 30, 2022 | 2.70B | -343.81M | -11.28% |
Sep 30, 2021 | 3.05B | 207.54M | 7.31% |
Sep 30, 2020 | 2.84B | 467.81M | 19.73% |
Sep 30, 2019 | Pro | Pro | Pro |
Sep 30, 2018 | Pro | Pro | Pro |
Sep 30, 2017 | Pro | Pro | Pro |
Sep 30, 2016 | Pro | Pro | Pro |
Sep 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition